Breast Cancer

Adjuvant Chemotherapy for Breast Cancer: Adverse Effects Transient

Published in Cancer Weekly, May 20th, 1996

Women who undergo adjuvant chemotherapy for early breast cancer report measurable adverse effects on the quality of life, according to a report in the Lancet 1996;347:1279-1284.

However, these effects are "... transient and less substantial than the process of adap[ta]tion to the disease," according to researchers with the International Breast Cancer Study Group.

Dr. Christoph Hurny of Bern, Switzerland, and colleagues dispensed a quality-of-life questionnaire to women with node-positive operable breast cancer.

The subjects were assigned to one of two treatment groups: 1,475 received adjuvant chemotherapy and 1,212 received...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-05-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry